Top Markets
#1 Derive Derive +30.84%
#2 Cross Cross +17.10%
#3 Audiera Audiera +15.13%
#4 Humanity Humanity +10.96%
#5 Cap Cap +10.49%
#6 Velvet Velvet +10.37%
#7 The Bitcoin Bull The Bitcoin Bull +10.22%
#8 Geodnet Geodnet +8.81%
#9 Based Based +8.66%
#10 Biconomy Biconomy +7.67%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Clasificación en acciones #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Precio por acción
$0.46
Última sincronización: 2026-07-31
Capitalización bursátil
$3.42M
Cambio (1 día)
3.60%
Cambio (1 año)
-34.54%
País
US
Comercio Pasithea Therapeutics Corp. (KTTA)

Categoría

Healthcare
Ratio P/B de Pasithea Therapeutics Corp. (KTTA)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Pasithea Therapeutics Corp., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Pasithea Therapeutics Corp. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE